RGS vs PG

For growth investors, Regis Corporation (RGS) is the stronger pick with 3.

5% revenue growth year-over-year, versus 0. 3% for The Procter & Gamble Company (PG). Regis Corporation (RGS) offers the better valuation at 0. 6x trailing P/E, making it the more compelling value choice. Analysts rate The Procter & Gamble Company (PG) a "Buy" — based on 52 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Regis Corporation (RGS) is the cheapest at 0.

6x versus The Procter & Gamble Company at 22. 7x.

Over the past 5 years, The Procter & Gamble Company (PG) delivered a total return of +23.

8%, compared to -86. 9% for Regis Corporation (RGS). Over 10 years, the gap is even starker: PG returned +121. 5% versus RGS's -90. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), The Procter & Gamble Company (PG) is the lower-risk stock at 0.

10β versus Regis Corporation's 0. 79β — meaning RGS is approximately 658% more volatile than PG relative to the S&P 500. On balance sheet safety, The Procter & Gamble Company (PG) carries a lower debt/equity ratio of 68% versus 189% for Regis Corporation — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Regis Corporation (RGS) is pulling ahead at 3.

5% versus 0. 3% for The Procter & Gamble Company (PG). On earnings-per-share growth, the picture is similar: Regis Corporation grew EPS 13. 9% year-over-year, compared to 8. 1% for The Procter & Gamble Company. Over a 3-year CAGR, PG leads at 1. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Regis Corporation (RGS) is the more profitable company, earning 58.

8% net margin versus 19. 0% for The Procter & Gamble Company — meaning it keeps 58. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PG leads at 24. 3% versus 9. 5% for RGS. At the gross margin level — before operating expenses — PG leads at 51. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

In this comparison, PG (2.

7% yield) pays a dividend. RGS does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, The Procter & Gamble Company (PG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

10), 2. 7% yield, +121. 5% 10Y return). Both have compounded well over 10 years (PG: +121. 5%, RGS: -90. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (RGS (Consumer Cyclical) and PG (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: RGS is a small-cap deep-value stock; PG is a large-cap quality compounder stock. PG pays a dividend while RGS does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.